Day: September 21, 2026

Learn how an IND application moves from preclinical evidence to FDA review. This guide explains forms, CMC, toxicology, clinical protocols, exemptions, eCTD submission, expanded access, clinical holds, and the 30-day process. Use it to prepare clearer, review-ready submissions for development teams in 2026.